# LHRH-Conjugated Magnetite Nanoparticles and Nanorods as Magnetic Resonance Imaging Contrast Agents for Targeting Triple-Negative Breast Cancer

**Authors:** Chukwudi C. Ezeala, John D. Obayemi, Ali A. Salifu, Theresa Ezenwafor, Yiporo Danyuo, Maria Chinyerem Onyekanne, Stanley C. Eluu, Toyin Aina, Josephine Oparah, Precious O. Etinosa, Olushola S. Odusanya, Winston O. Soboyejo

PMC · DOI: 10.3390/jfb17030134 · Journal of Functional Biomaterials · 2026-03-10

## TL;DR

This study shows that nanorod-shaped magnetite nanoparticles conjugated with LHRH improve MRI imaging of triple-negative breast cancer tumors in mice compared to spherical-shaped nanoparticles.

## Contribution

The novel contribution is demonstrating that nanorod-shaped, LHRH-conjugated magnetite nanoparticles enhance MRI contrast for targeting TNBC tumors.

## Key findings

- Nanorod-shaped LHRH-conjugated MNPs provided higher-resolution T2-weighted MRI scans of TNBC tumors.
- Functionalized MNPs showed better tumor targeting than non-functionalized or spherical-shaped MNPs.
- MRI scans were obtained before and after MNP injection to assess contrast enhancement.

## Abstract

This paper presents the results of an experimental study on the effects of magnetite nanoparticle (MNP) shape on magnetic resonance imaging (MRI) of triple-negative breast cancer (TNBC) xenograft tissues. T2-weighted MRI scans using spherical shaped MNPs as contrast agents are compared to MRI scans done with nanorod-shaped MNPs as contrast agents. The MNPs were first coated with polyethylene glycol (PEG) and subsequently conjugated to luteinizing hormone-releasing hormone (LHRH) to specifically target LHRH receptors, which are present at high levels on the surfaces of xenograft TNBC cells/tissues. After 3 weeks of tumor growth in nude immunocompromised mice, LHRH-conjugated (functionalized) and unconjugated (non-functionalized) MNPs were injected into the immunocompromised mice. Four types of MNPs were used: non-functionalized nanorod-shaped MNPs (BMNR); LHRH-conjugated nanorod-shaped MNPs (LCMNR); non-functionalized spherical-shaped MNPs (BSSMNP); and LHRH-conjugated spherical-shaped MNPs (LCSSMNP). T2-weighted magnetic resonance imaging (MRI) scans were obtained from the mice before the injection of the MNPs and two hours after the injection of the MNPs. The results show that using nanorod-shaped LHRH-conjugate MNPs as contrast agents yielded higher-resolution T2-weighted MRI scans of TNBC tumors compared to those from spherical-shaped MNPs. The implications of the results are discussed in relation to potential applications of functionalized MNPs in MRI for TNBC diagnosis.

## Linked entities

- **Chemicals:** polyethylene glycol (PubChem CID 9033)
- **Diseases:** triple-negative breast cancer (MONDO:0005494)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, Gnrh1 (gonadotropin releasing hormone 1) [NCBI Gene 14714] {aka Gnrh, Gnrh2, LHRH, Lhrh1, Lnrh, hpg}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672] {aka BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4}
- **Diseases:** TNBC (MESH:D064726), Tumor (MESH:D009369), injury to (MESH:D014947), LCSSMNP (MESH:C565870), Cytotoxicity (MESH:D064420), Breast Cancer (MESH:D001943), necrosis (MESH:D009336)
- **Chemicals:** H&amp;E (MESH:D006371), penicillin (MESH:D010406), O (MESH:D010100), ethanol (MESH:D000431), carbon (MESH:D002244), oil (MESH:D009821), E (MESH:D004540), PEG (MESH:D011092), iron (II) sulphate heptahydrate (MESH:C020748), Magnetite (MESH:D052203), hydrazine (MESH:C029424), H (MESH:D006859), streptomycin (MESH:D013307), isoflurane (MESH:D007530), FeOOH (-), DI (MESH:D014867), gold (MESH:D006046), Prussian Blue (MESH:C000170), sodium hydroxide (MESH:D012972), Cu (MESH:D003300), argon (MESH:D001128), nitrogen (MESH:D009584), hydrochloric acid (MESH:D006851), iron oxide (MESH:C000499), glutaraldehyde (MESH:D005976), Fe (MESH:D007501), Eosin (MESH:D004801), iron oxyhydroxide (MESH:C021024), Hematoxylin (MESH:D006416)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** MDA-MB 231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13026907/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13026907/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC13026907/full.md

---
Source: https://tomesphere.com/paper/PMC13026907